Dermatology News and Research

Latest Dermatology News and Research

PreCision Dermatology formed as a result of spin-out of Onset Therapeutics

PreCision Dermatology Inc., a company focused on developing, manufacturing, acquiring and marketing a broad portfolio of innovative dermatology products, today announced it was formed as the result of the spin-out of Onset Therapeutics, a wholly-owned subsidiary of Collegium Pharmaceutical, Inc. PreCision Dermatology also announced the close of a Series A financing led by life science private equity investor Essex Woodlands.

2 Dec 2010

Study reveals role of VSV in killing cancer cells through turning off major survival signal

Researchers from Boston University School of Medicine (BUSM) have identified a mechanism by which specific viruses acting as oncolytic agents can enter and kill cancer cells. This finding, which is currently featured in an online edition of the Journal of Virology, could help lead to the development of more targeted treatments against many types of cancer.

2 Dec 2010

GSK and Valeant receive FDA Complete Response letter for ezogabine

GlaxoSmithKline and Valeant Pharmaceuticals International, Inc. announced receipt of a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the New Drug Application (NDA) for ezogabine, an investigational anti-epileptic drug being studied for the adjunctive treatment of adults with partial-onset seizures.

2 Dec 2010

Collegium completes spin-out of Onset Therapeutics

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced today that it has completed the spin-out of Onset Therapeutics, LLC, its wholly owned subsidiary focused on the Dermatology market.

2 Dec 2010

Researchers show an oncolytic virus switches off cancer cell survival signal

1 Dec 2010

Elorac's naloxone lotion receives FDA Orphan Drug Designation for pruritus associated with mycosis fungoides

Elorac, Inc., a rapidly growing specialty pharmaceutical company focused on the treatment of dermatological disorders announced that it has been granted Orphan Drug Designation by the U.S. Food and Drug Administration for its naloxone lotion for the topical treatment of pruritus accompanying cutaneous t-cell lymphoma (CTCL, also known as mycosis fungoides).

1 Dec 2010

Syneron launches CO2RE CO2 resurfacing system in US and Canada

Syneron Medical Ltd., the global leader in the medical aesthetic device marketplace, announced today the US Food and Drug Administration (FDA) and Health Canada clearance and commercial launch of its highly flexible CO2RE CO2 resurfacing system. CO2RE is a versatile fractional CO2 system that offers the unique ability to treat both superficial and deep skin layers simultaneously with precision-control over the intensity, pattern and depth of ablation.

30 Nov 2010

Apricus announces publication of NexACT technology data in Pharmaceutics Journal

Apricus Biosciences, Inc., announced today that the International Journal of Pharmaceutics, a peer reviewed journal, has published new data on the NexACT technology in their November 2010 issue, based on research conducted by, and at, the Ernest Mario School of Pharmacy, Rutgers-The State University of New Jersey in Piscataway, NJ.

30 Nov 2010

Australia’s largest skin cancer study

More than 400,000 people will be diagnosed with some form of skin cancer this year and the most deadly form of the disease, melanoma, will claim more than a thousand lives in Australia say researchers. Queensland has the highest rate of skin cancer in the world with fair-skinned people being most affected with the strong subtropical sun.

29 Nov 2010

Sun protection education to begin early

In a bid to prevent skin cancer the June E. Nylon Cancer Center has received a grant from the Ronald McDonald House Charities in the amount of $1,590 to fund treatments for sun damage among for students in the Sioux City Community Schools and also provide sunscreens to them.

29 Nov 2010

Ontario's doctors urge province to follow Nova Scotia's decision on tanning beds

Ontario's doctors are calling on the province to follow Nova Scotia's lead and move to protect young people from the dangers of tanning beds. In Nova Scotia, the government recently announced a ban on the use of tanning beds for those under 19.

29 Nov 2010

Response to PLX4032 drug short lived in BRAF-mutated metastatic melanoma patients

Researchers with UCLA's Jonsson Comprehensive Cancer Center have found that melanoma patients whose cancers are caused by mutation of the BRAF gene become resistant to a promising targeted treatment through another genetic mutation or the overexpression of a cell surface protein, both driving survival of the cancer and accounting for relapse.

25 Nov 2010

Bacterial study confirms TLR2 signaling vital for activating human airway epithelial cells

Researchers from the Boston University School of Medicine (BUSM) have demonstrated that commensal species of the genus Neisseriae are low inducers of human airway epithelial cell responses as compared to the pathogenic species.

24 Nov 2010

Provectus reports progress in PV-10 program for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, reports continued progress in its compassionate use program for PV-10. The program currently has enrolled more than 40 patients, ten of whom are expanded access patients from the company's Phase 2 trial of PV-10 for metastatic melanoma, as well as more than 30 new patients.

24 Nov 2010

Botox Cosmetics increase overall quality of life and self-esteem

Chicago Facial Plastic Surgeon, Steven H. Dayan, MD, FACS, publishes a study in the November 2010 issue of Dermatologic Surgery, a prominent Dermatology journal, demonstrating that increases in overall quality of life and self-esteem were observed in participants treated with Botulinum Toxin Type A or Botox Cosmetic. In this double-blind randomized placebo-controlled survey, Dr. Dayan and DeNova research worked with one hundred participants who were treated with either Botox Cosmetic or a saline placebo for facial wrinkles.

23 Nov 2010

AADA releases updated position statement on isotretinoin usage

The American Academy of Dermatology Association (AADA) recently updated its position statement on the use of isotretinoin. The position continues to state that patient safety is dermatologists' primary concern and that the AADA is committed to the safe and responsible use of isotretinoin, which is the most effective treatment for severe acne.

23 Nov 2010

Apricus files protocol of PrevOnco Phase 3 clinical trial for FDA SPA program

Apricus Biosciences, Inc., today announced that it has filed the protocol for a proposed Phase 3 clinical trial of PrevOnco, its proprietary treatment for hepatocellular carcinoma (liver cancer), with the U.S. Food and Drug Administration (FDA).

23 Nov 2010

Researchers develop three-dimensional cancer cell from normal human tissue in culture dish

Researchers at the Stanford University School of Medicine have successfully transformed normal human tissue into three-dimensional cancers in a tissue culture dish for the first time. Watching how the cells behave as they divide and invade surrounding tissue will help physicians better understand how human cancers act in the body. The new technique also provides a way to quickly and cheaply test anti-cancer drugs without requiring laboratory animals.

22 Nov 2010

NexACT technology improves oral delivery of five small molecule drugs

Apricus Biosciences, Inc., today announced data from animal studies showing that the NexACT technology significantly improved the oral delivery of five small molecule drugs tested, with the best improvements up to 20-fold, in terms of improvement in absorption.

20 Nov 2010

Experts formulate research related to psychological adjustment and traumatic brain injury

Five U.S. federal agencies recently cosponsored a set of expert work groups to formulate common data elements for research related to psychological adjustment and traumatic brain injury (TBI).

19 Nov 2010

Dermatology News and Research

Latest Dermatology News and Research

PreCision Dermatology formed as a result of spin-out of Onset Therapeutics

Study reveals role of VSV in killing cancer cells through turning off major survival signal

GSK and Valeant receive FDA Complete Response letter for ezogabine

Collegium completes spin-out of Onset Therapeutics

Researchers show an oncolytic virus switches off cancer cell survival signal

Elorac's naloxone lotion receives FDA Orphan Drug Designation for pruritus associated with mycosis fungoides

Syneron launches CO2RE CO2 resurfacing system in US and Canada

Apricus announces publication of NexACT technology data in Pharmaceutics Journal

Australia’s largest skin cancer study

Sun protection education to begin early

Ontario's doctors urge province to follow Nova Scotia's decision on tanning beds

Response to PLX4032 drug short lived in BRAF-mutated metastatic melanoma patients

Bacterial study confirms TLR2 signaling vital for activating human airway epithelial cells

Provectus reports progress in PV-10 program for metastatic melanoma

Botox Cosmetics increase overall quality of life and self-esteem

AADA releases updated position statement on isotretinoin usage

Apricus files protocol of PrevOnco Phase 3 clinical trial for FDA SPA program

Researchers develop three-dimensional cancer cell from normal human tissue in culture dish

NexACT technology improves oral delivery of five small molecule drugs

Experts formulate research related to psychological adjustment and traumatic brain injury

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dermatology News and Research

Latest Dermatology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in